Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: A pilot study
L Gu, S Li, Y He, Y Chen, Y Jiang, Y Peng, X Liu… - …, 2019 - Wiley Online Library
Background Bismuth‐containing quadruple therapy (BQT) is a recommended alternative first‐
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …
Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: a pilot study.
L Gu, SL Li, Y He, Y Chen, YZ Jiang, Y Peng, XW Liu… - Helicobacter, 2019 - cabdirect.org
Background: Bismuth-containing quadruple therapy (BQT) is a recommended alternative
first-line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy …
first-line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy …
Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: A pilot study
L Gu, S Li, Y He, Y Chen, Y Jiang, Y Peng… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Bismuth-containing quadruple therapy (BQT) is a recommended alternative first-
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …
Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
L Gu, S Li, Y He, Y Chen, Y Jiang, Y Peng, X Liu… - Helicobacter, 2019 - europepmc.org
BACKGROUND: Bismuth-containing quadruple therapy (BQT) is a recommended alternative
first-line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy …
first-line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy …
Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: A pilot study
L Gu, S Li, Y He, Y Chen, Y Jiang, Y Peng, X Liu… - Helicobacter, 2019 - infona.pl
Background Bismuth‐containing quadruple therapy (BQT) is a recommended alternative first‐
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …
Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: a pilot study.
GL Gu Lei, LSL Li ShengLan, HY He Ying, CY Chen Yi… - 2019 - cabidigitallibrary.org
Background: Bismuth-containing quadruple therapy (BQT) is a recommended alternative
first-line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy …
first-line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy …